Blog

Zacks Investment Research has recently initiated coverage of Timberland Bancorp, Inc. TSBK with a Neutral recommendation, reflecting the company's solid financial performance, while recognizing the

Figma FIG and Autodesk ADSK are both benefiting from AI integration in the design SaaS space. Although Figma offers collaborative digital product design, Autodesk provides engineering and industrial

Darden Restaurants, Inc. DRI reported fourth-quarter fiscal 2026 results, with earnings beating the Zacks Consensus Estimate and revenues missing the same. The top and bottom lines increased on a

D-Wave Quantum QBTS, or D-Wave, recently announced its forthcoming gate-model quantum computing simulator, a move that expands its gate-model roadmap designed to accelerate the development of

The Boston Beer Company SAM narrowed its 2026 volume outlook after reporting weaker-than-expected first-quarter results, reflecting persistent softness across parts of its brand portfolio and an

The quick-service restaurant industry continues to navigate a challenging consumer environment, with value offerings, digital engagement and international expansion playing increasingly important

Genpact’s G top line benefits from its dominance in Business Process Outsourcing (BPO) services worldwide. The company’s artificial intelligence (AI)-driven solutions accelerate clients’ digital

Regional banking institutions continue to operate within an environment influenced by interest rate volatility, regulatory requirements and evolving customer needs. Within this backdrop, Peoples

Thursday, June 25th, 2026Pre-market futures, following Micron’s MU epic fiscal Q3 earnings, are all in the green — led by the Nasdaq’s +700 points at this hour. The blue-chip Dow is showing gains of

Anixa Biosciences ANIX has built a diversified oncology pipeline centered on two innovative platforms, cancer vaccines and cell-based immunotherapies. The company's lead programs include a breast

GE Vernova GEV and Public Service Enterprise Group PEG are positioned to benefit from rising electricity demand and grid modernization. As economies become increasingly dependent on electricity for

Quest Diagnostics’ DGX Haystack MRD test recently received approval from the New York State Department of Health's (“NYSDOH”) Clinical Laboratory Evaluation Program (“CLEP”) for use in identifying

Stitch Fix SFIX is strengthening its artificial intelligence (AI) capabilities with the expansion of Stitch Fix Vision, enabling clients to generate personalized images of themselves wearing

Neogen Corporation NEOG is well poised to gain in the coming quarters, thanks to its continued product development efforts that enhance its existing offerings and advance its business strategy. The

The AI-driven semiconductor upcycle has created significant opportunities for emerging chip suppliers positioned in high-growth infrastructure markets, and both AXT AXTI and Diodes DIOD are

Advanced Micro Devices AMD EPYC CPUs and Instinct GPUs now power four of the world's 10 fastest supercomputers and four of the 10 most energy-efficient systems, underscoring its growing presence in

Vishay Intertechnology VSH appears to be steadily strengthening its competitive position in the automotive semiconductor market as accelerating electrification trends create new long-term growth

Absci ABSI shares surged 36% on Wednesday after the company reported positive interim data from the phase I portion of its ongoing phase I/IIa HEADLINE study evaluating ABS-201, an investigational

STMicroelectronics N.V. STM is strengthening its position in the fast-growing sensor market through the acquisition of NXP's MEMS sensor business. This move could reinforce its leadership in

If you still think of The Cigna Group CI as just a traditional health insurer, it may be time for a second look. The company is steadily expanding beyond insurance, building a broader healthcare

Micron Technology MU reported third-quarter fiscal 2026 non-GAAP earnings of $25.11 per share, beating the Zacks Consensus Estimate by 17.39%. The company reported earnings of $1.91 per share in the

Gilead Sciences, Inc. GILD obtained approval FDA approved for the label expansion of breast cancer drug Trodelvy (sacituzumab govitecan-hziy), a first-in-class Trop-2-directed antibody-drug

For investors seeking momentum, Bahl & Gaynor Small/Mid Cap Income Growth ETF SMIG is probably on the radar now. The fund just hit a 52-week high and jumped 17.8% from its 52-week low price of

American Express Company AXP is expanding its commercial payments business through another targeted partnership. Together with Mercantile and the American Bar Association (“ABA”), AmEx has